Zonisamide: its pharmacology, efficacy and safety in clinical trials. - Wikidata - wikimedia - TriplyDB

Zonisamide: its pharmacology, efficacy and safety in clinical trials.

Zonisamide: its pharmacology, efficacy and safety in clinical trials.

http://www.wikidata.org/entity/Q38056166

about

Zonisamide for neuropathic pain in adults Zonisamide for neuropathic pain in adults Zonisamide in the management of epilepsy in the elderly Update on once-daily zonisamide monotherapy in partial seizures Profile of once-daily zonisamide as monotherapy for treatment of partial seizures in adults Zonisamide, topiramate, and levetiracetam: efficacy and neuropsychological effects in alcohol use disorders Safety and Efficacy of Zonisamide in Patients with Epilepsy: A Post-Marketing Surveillance Study Evaluation of safety and efficacy of zonisamide in adult patients with partial, generalized, and combined seizures: an open labeled, noncomparative, observational Indian study.Age-related downregulation of the CaV3.1 T-type calcium channel as a mediator of amyloid beta production.Anticonvulsant/antiepileptic carbonic anhydrase inhibitors: a patent review.Zonisamide: a review of its use in the management of adults with partial seizures.Zonisamide: a review of its use as adjunctive therapy in the management of partial seizures in pediatric patients aged ≥6 years.Zonisamide: Review of Recent Clinical Evidence for Treatment of Epilepsy.Synergism of perampanel and zonisamide in the rat amygdala kindling model of temporal lobe epilepsy.Retention rate of zonisamide in intractable epilepsy.Safety and tolerability of zonisamide in elderly patients with epilepsy.Molecular bases of anorexia nervosa, bulimia nervosa and binge eating disorder: shedding light on the darkness.A pharmaco-EEG-based assessment of the interaction between ethanol and zonisamide.

P2860

Q24186542-B94F2ADC-4F40-4D04-9BD3-84B802047D8A Q24194963-6753C5F2-B0A2-4E56-AEDE-5C2394DE2291 Q26820856-DF5F05B4-7F79-4194-AED0-527D7F9FD399 Q26863573-9295BD30-BD97-45EE-9B4E-85522859D78A Q26995736-442B802C-C244-468E-BF3F-9307AD8F8C15 Q30611398-B4521CF0-64F3-4A80-BC0A-EF88BC1E5CB2 Q36496058-2A904419-E1B4-48F0-84BA-1427033A553D Q36653057-5DD2A725-8E5B-4DF6-AAD6-D7D31F2EC5FF Q37610928-C39E98A2-5B06-4C33-AF21-A5F5734A8361 Q38091452-9C1B8D70-F860-4A77-82DF-FE0F9561257C Q38123123-F9F09A9F-9299-4908-9B44-C47BC951B539 Q38199380-8429055C-4E30-422F-AD52-AF498F188171 Q38553039-D96C838D-45A7-460C-9A6F-0A7825F3C98F Q40016074-F70F0D81-60E2-458B-8D84-220A2F1F2C86 Q41490988-EAF7D29A-4422-4022-9FC1-C9C5968EF3FC Q44037728-3649967F-145A-4CDB-A024-1BD771831E85 Q47656495-C3C8CC1E-38B1-4F1E-BB51-0B176581AA1D Q48711916-F36C4F66-5666-4C02-94A6-4DDB6EB19983

P2860

Zonisamide: its pharmacology, efficacy and safety in clinical trials.

http://www.wikidata.org/entity/Q38056166

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Zonisamide: its pharmacology, efficacy and safety in clinical trials.

@en

type

label

Zonisamide: its pharmacology, efficacy and safety in clinical trials.

@en

prefLabel

Zonisamide: its pharmacology, efficacy and safety in clinical trials.

@en

P1433

Q38056166-1CD41885-40D9-45B8-8D58-43BAA603FA29

P1476

Q38056166-D7586F98-7E51-48A1-BDDE-064761D241DA

P2093

Q38056166-208EEE93-8AA5-4BF9-90AF-5480C55D7C27

Q38056166-36439B16-B696-4064-B91A-148EDF3A910F

Q38056166-7BF917AB-5568-480D-ABC4-71691EBFACDD

Q38056166-AC5ED789-00F8-44BF-9536-541665D0CE0D

P2860

Q38056166-0161769D-6B74-4D1F-85F4-4C3EBF25FC5B

Q38056166-0D03F759-498D-4C92-BD64-5962AD6A9CBA

Q38056166-10036DC1-6CBE-4865-8EF3-40FED930FBE4

Q38056166-12F57393-910A-4480-9733-48F6E137950F

Q38056166-164500BD-4C1B-44A5-BB90-7FB195C64630

Q38056166-1DDEB366-0895-43A6-B4BD-5DCD1BB385E4

Q38056166-210A887A-A3FF-489B-A288-85AFC56A5277

Q38056166-25EA70FB-9C03-43D7-9CDD-04285E0A7020

Q38056166-421811D8-DE49-4667-9A3B-A1A1E2AA82AC

Q38056166-4C892E11-1FC3-4F55-8F14-42F556AFB0A5

P304

Q38056166-F2FBF695-3487-4746-8932-E9B64FC5DE3C

P31

Q38056166-66CEA121-650F-4BB9-A815-FA04B92BBAD7

P356

Q38056166-3B641444-2AE3-4180-80FA-FED6F4825F83

P433

Q38056166-C5D353AE-D8BB-43E2-9B24-42663C9F1B72

P577

Q38056166-A854269A-9592-416D-AB80-DE39BEDC41DD

P698

Q38056166-FE8CF12D-72D8-4A60-B910-C525685C7CA8

P921

Q38056166-459869A9-748D-4DA8-B3A1-E0B32E3972D8

P356

P1433

Acta neurologica Scandinavica. Supplementum

P1476

Zonisamide: its pharmacology, efficacy and safety in clinical trials.

@en

P2093

E Ben-Menachem

http://www.w3.org/2001/XMLSchema#string

I Chouette

http://www.w3.org/2001/XMLSchema#string

L Giorgi

http://www.w3.org/2001/XMLSchema#string

M J Brodie

http://www.w3.org/2001/XMLSchema#string

P2860

ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes.

Effect of zonisamide on molecular regulation of glutamate and GABA transporter proteins during epileptogenesis in rats with hippocampal seizures.

Effect of antiepileptic drugs on bodyweight: overview and clinical implications for the treatment of epilepsy.

Zonisamide as adjunctive therapy for refractory partial seizures.

Pharmacokinetics and drug interactions with zonisamide.

Weight issues for people with epilepsy--a review.

Zonisamide in the treatment of epilepsy.

Studies on 3-substituted 1,2-benzisoxazole derivatives. 6. Syntheses of 3-(sulfamoylmethyl)-1,2-benzisoxazole derivatives and their anticonvulsant activities.

Carbamazepine pharmacokinetics are not affected by zonisamide: in vitro mechanistic study and in vivo clinical study in epileptic patients.

The genetic animal model of reflex epilepsy in the Mongolian gerbil: differential efficacy of new anticonvulsive drugs and prototype antiepileptics.

P304

19-28

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/ANE.12016

http://www.w3.org/2001/XMLSchema#string

P433

194

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23106522

http://www.w3.org/2001/XMLSchema#string

P921